OGC
Oak Grove Capital’s Gilead Sciences GILD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $532K | Sell |
4,800
-7,200
| -60% | -$798K | 0.09% | 47 |
|
2025
Q1 | $1.34M | Hold |
12,000
| – | – | 0.28% | 38 |
|
2024
Q4 | $1.11M | Hold |
12,000
| – | – | 0.17% | 40 |
|
2024
Q3 | $1.01M | Buy |
12,000
+1,400
| +13% | +$117K | 0.16% | 37 |
|
2024
Q2 | $727K | Buy |
+10,600
| New | +$727K | 0.13% | 35 |
|
2022
Q2 | – | Sell |
-6,400
| Closed | -$380K | – | 69 |
|
2022
Q1 | $380K | Sell |
6,400
-4,450
| -41% | -$264K | 0.08% | 61 |
|
2021
Q4 | $788K | Sell |
10,850
-3,800
| -26% | -$276K | 0.14% | 57 |
|
2021
Q3 | $1.02M | Sell |
14,650
-25,531
| -64% | -$1.78M | 0.22% | 52 |
|
2021
Q2 | $2.77M | Sell |
40,181
-37,171
| -48% | -$2.56M | 0.62% | 37 |
|
2021
Q1 | $5M | Sell |
77,352
-1,600
| -2% | -$103K | 1.4% | 25 |
|
2020
Q4 | $4.6M | Buy |
78,952
+12,602
| +19% | +$734K | 1.5% | 26 |
|
2020
Q3 | $4.19M | Buy |
66,350
+30,171
| +83% | +$1.91M | 1.98% | 17 |
|
2020
Q2 | $2.78M | Sell |
36,179
-59,850
| -62% | -$4.61M | 1.68% | 15 |
|
2020
Q1 | $7.18M | Sell |
96,029
-102,496
| -52% | -$7.66M | 4.64% | 5 |
|
2019
Q4 | $12.9M | Sell |
198,525
-3,350
| -2% | -$218K | 5.04% | 3 |
|
2019
Q3 | $12.8M | Buy |
201,875
+96,100
| +91% | +$6.09M | 5.55% | 4 |
|
2019
Q2 | $7.15M | Buy |
105,775
+52,800
| +100% | +$3.57M | 3.82% | 6 |
|
2019
Q1 | $3.44M | Buy |
52,975
+22,350
| +73% | +$1.45M | 2.17% | 15 |
|
2018
Q4 | $1.92M | Buy |
30,625
+13,300
| +77% | +$832K | 1.71% | 16 |
|
2018
Q3 | $1.34M | Sell |
17,325
-500
| -3% | -$38.6K | 1.15% | 22 |
|
2018
Q2 | $1.26M | Buy |
17,825
+2,400
| +16% | +$170K | 1.28% | 20 |
|
2018
Q1 | $1.16M | Sell |
15,425
-13,050
| -46% | -$984K | 1.28% | 18 |
|
2017
Q4 | $2.04M | Buy |
+28,475
| New | +$2.04M | 2.12% | 14 |
|